Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur TAKEDA PHARMACEUTICAL COMPANY LIMITED
21/01TAKEDA PHARMACEUTICAL : to Hold Third Quarter FY2021 Earnings Conference Call
20/01Takeda Named Global Top Employer for Fifth Consecutive Year
13/01Denali Therapeutics Shares Fall as FDA Puts Alzheimer's Study Plan on Hold
13/01Takeda Pharmaceutical Buys Back $434 Million of Shares as Part of Buyback Program Set t..
13/01Takeda destaca su estrategia para lograr un crecimiento sostenible durante la próxima d..
12/01Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40..
12/01S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills
12/01S.Korea authorizes Novavax COVID-19 vaccine, imports Pfizer pills
11/01Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta T Cell Engager ..
11/01Takeda unterstreicht Strategie für nachhaltiges Wachstum in den nächsten zehn Jahren au..
11/01Takeda Pharmaceutical Says Its Global Brands Are Expected to Hit Revenue Growth Target
11/01Takeda übernimmt Adaptate Biotherapeutics zur Entwicklung neuartiger Gamma-delta-(&gamm..
11/01PRESENTATION : Better health for people, Brighter future for the world
11/01ADRs End Higher; BioNTech, Veolia Among Companies Actively Trading
10/01TAKEDA PHARMACEUTICAL : Emphasizes Strategy for Delivering Sustainable Growth Over Next De..
10/01Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40..
10/01Takeda adquiere Adaptate Biotherapeutics para desarrollar nuevas terapias de activación..
10/01Takeda Pharmaceutical to Acquire Adaptate Biotherapeutics to Accelerate Development of ..
10/01Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ..
10/01Takeda Pharmaceutical Company Limited exercised an option to acquire Adaptate Biotherap..
05/01Takeda to Present at The 40th Annual J.P. Morgan Healthcare Conference
05/01TAKEDA PHARMACEUTICAL : to Present at The 40th Annual JP Morgan Healthcare Conference
05/01Tranche Update on Takeda Pharmaceutical Company Limited's Equity Buyback Plan announced..
2021Novavax to submit COVID-19 vaccine EUA request to U.S. FDA next month
2021Astria Therapeutics' Hereditary Angioedema Drug Shows Promise Ahead of Clinical Testing..
2021Japanese Shares Witness Strong Rally; J. Front to Develop Non-Retail Assets
2021Takeda Pharmaceutical to Supply Additional Doses of Moderna's COVID-19 Vaccine in 2022
2021Japan swells booster arsenal with 18 million more doses of Moderna vaccine
2021TAKEDA PHARMACEUTICAL : Moderna and the Japanese Government Collaborate to Increase Modern..
2021Takeda, Moderna and the Japanese Government Collaborate to Increase Moderna’S COVI..
2021Japanese shares end higher on Wall St boost, airlines shine
2021Japanese shares track Wall Street higher, Omicron concerns weigh
2021Takeda Pharmaceutical's Drug Candidate for Eosinophilic Esophagitis Recommended for Add..
2021Takeda erhält vollständiges Antwortschreiben von der US-amerikanischen FDA für TAK-721
2021Takeda recibe carta de respuesta completa de la FDA de EE. UU. para TAK-721
2021Takeda Gets Complete Response Letter From FDA for TAK-721
2021Takeda Receives Complete Response Letter from the U.S. FDA for TAK-721
2021Takeda Pharmaceutical Company Limited Receives Complete Response Letter from the U.S. F..
2021Ambys Medicines, Inc. announced that it has received $107 million in funding from Third..
2021Takeda Receives Positive CHMP Opinion for Vedolizumab IV for the Treatment of Active Ch..
2021El regulador de la UE da luz verde a Novavax como quinta vacuna de COVID del bloque
2021EU backs Novavax shot as region's fifth COVID-19 vaccine
2021Takeda's Active Chronic Pouchitis Treatment Backed by European Medicines Agency Committ..
2021Takeda Receives Positive CHMP Opinion for Vedolizumab IV for the Treatment of Active Ch..
2021Takeda Pharmaceutical Company Limited Receives Positive CHMP Opinion for Vedolizumab IV..
2021Takeda Files New Drug Application for Novavax' COVID-19 Vaccine Candidate in Japan
2021Japan PM Kishida speeds boosters and secures Pfizer pills amid Omicron fears
2021Takeda Pharmaceutical - Maintaining trust in science is crucial to public health. Here'..
2021Novavax Files New Drug Application in Japan for COVID-19 Vaccine
2021Novavax Seeks Japanese Approval for COVID-19 Jab
2021GENERAL ANNOUNCEMENT : :Takeda Submits New Drug Application for Novavax COVID-19 Vaccine C..
2021Japan approves Moderna COVID vaccine as booster, Novavax files for 1st approval
2021TAKEDA PHARMACEUTICAL : Submits New Drug Application for Novavax' COVID-19 Vaccine Candida..
2021Takeda submits approval request for Novavax's COVID-19 vaccine in Japan
2021Takeda Pharmaceutical Company Limited Submits New Drug Application for Novavax' COVID-1..
2021URGENT : Japan gov't panel OKs Moderna's COVID-19 vaccine as booster
2021Takeda Pharmaceutical Company Limited, National MPS Society, Luna, and Genetic Alliance..
2021Takeda Drives Continued Scientific Leadership through Real-World Evidence in Rare Hemat..
2021GENERAL ANNOUNCEMENT : :Share Repurchase Report (From November 1, 2021 to November 30, 202..
2021 Takeda Drives Continued Scientific Leadership Through Real-World Evidence in Rare Hema..
2021Kaken Pharmaceutical Co., Ltd. completed the acquisition of ARTham Therapeutics Inc for..
2021Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENC..
2021Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENC..
2021Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENC..
2021Takeda Unveils New Research to Advance Patient Care in Hematology and Oncology at 63rd ..
2021Takeda stellt auf der 63. Jahrestagung der American Society of Hematology (ASH) neue Fo..
2021Takeda presenta nueva investigación para mejorar la atención del paciente en hematologí..
2021Takeda Unveils New Research to Advance Patient Care in Hematology and Oncology at 63rd ..
2021Takeda Unveils New Research to Advance Patient Care in Hematology and Oncology at 63rd ..
2021Takeda's LIVTENCITYTM (maribavir) Now Available for Certain Individuals Ages 12 Years a..
2021Japanese Shares Close With Gains on Japan Services Data
2021Takeda Says Livtencity Commercially Available in the US for Patients 12 Years and Older
2021Takeda's LIVTENCITY™ (maribavir) Now Available for Certain Individuals Ages 12 Ye..
2021Takeda Pharmaceutical Company Limited Announces its LIVTENCITY? Now Available for Certa..
2021Takeda Pharmaceutical Buys Back Shares for $441 Million
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur TAKEDA PHARMACEUTICAL COMPANY LIMITED